{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15341662", "DateCompleted": {"Year": "2004", "Month": "10", "Day": "25"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2004", "Month": "09", "Day": "02"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "4", "PubDate": {"Year": "2004", "Month": "Sep", "Day": "02"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].", "Pagination": {"StartPage": "12", "MedlinePgn": "12"}, "Abstract": {"AbstractText": ["The morbidity and mortality associated with depression are considerable and continue to increase. Depression currently ranks fourth among the major causes of disability worldwide, after lower respiratory infections, prenatal conditions, and HIV/AIDS. Crocus sativus L. is used to treat depression. Many medicinal plants textbooks refer to this indication whereas there is no evidence-based document. Our objective was to compare the efficacy of stigmas of Crocus sativus (saffron) with imipramine in the treatment of mild to moderate depression in a 6-week pilot double-blind randomized trial.", "Thirty adult outpatients who met the Diagnostic and Statistical Manual of Mental Disorders, 4th edition for major depression based on the structured clinical interview for DSM IV participated in the trial. Patients have a baseline Hamilton Rating Scale for Depression score of at least 18. In this double-blind, single-center trial, patients were randomly assigned to receive capsule of saffron 30 mg/day (TDS) (Group 1) and capsule of imipramine 100 mg/day (TDS) (Group 2) for a 6-week study.", "Saffron at this dose was found to be effective similar to imipramine in the treatment of mild to moderate depression (F = 2.91, d.f. = 1, P = 0.09). In the imipramine group anticholinergic effects such as dry mouth and also sedation were observed more often that was predictable.", "The main overall finding from this study is that saffron may be of therapeutic benefit in the treatment of mild to moderate depression. To the best of our knowledge this is the first clinical trial that supports this indication for saffron. A large-scale trial with placebo control is warranted."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran 13185, Iran. s.akhond@neda.net"}], "Identifier": [], "LastName": "Akhondzadeh", "ForeName": "Shahin", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fallah-Pour", "ForeName": "Hasan", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Afkham", "ForeName": "Khosro", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jamshidi", "ForeName": "Amir-Hossein", "Initials": "AH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khalighi-Cigaroudi", "ForeName": "Farahnaz", "Initials": "F"}], "DataBankList": [{"DataBankName": "ISRCTN", "AccessionNumberList": ["ISRCTN45683816"]}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "OGG85SX4E4", "NameOfSubstance": "Imipramine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Crocus"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Imipramine"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Xerostomia"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Judd L. Mood disorders in the general population represent an important and worldwide public health problem. Int J Clin Psychopharm. 1995;10:5\u201310.", "ArticleIdList": ["8930004"]}, {"Citation": "Richelson E. Pharmacology of antidepressants-characteristic of the ideal drug. Mayo Clin Proc. 1994;69:1069\u20131081.", "ArticleIdList": ["7967761"]}, {"Citation": "Demyttenaere K. Compliance during treatment with antidepressants. J Affec Dis. 1997;43:27\u201339. doi: 10.1016/S0165-0327(96)00095-X.", "ArticleIdList": ["10.1016/S0165-0327(96)00095-X", "9127828"]}, {"Citation": "Donoghue JM, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry. 1996;168:164\u2013168.", "ArticleIdList": ["8837905"]}, {"Citation": "MacDonald TM. Treatment of depression: prescription for success? Prim Care Psychiatry. 1997;3:7\u201310."}, {"Citation": "Ernst E. St. John's wort, an anti-depressant? A systematic, criteria based review. Phytomedicine. 1995;2:67\u201371.", "ArticleIdList": ["23196103"]}, {"Citation": "De Smet PAGM, Nolen WA. St. John's wort as an antidepressant. BMJ. 1996;313:241\u2013242.", "ArticleIdList": ["PMC2351659", "8704522"]}, {"Citation": "Rios JL, Recio MC, Giner RM, Manez S. An update review of saffron and its active constituents. Phtother Res. 1996;10:189\u2013193. doi: 10.1002/(SICI)1099-1573(199605)10:3<189::AID-PTR754>3.0.CO;2-C.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199605)10:3<189::AID-PTR754>3.0.CO;2-C"]}, {"Citation": "Karimi G, Hosseinzadeh H, Khaleghpanah P. Study of antidepressant effect of aqueous and ethanolic of Crocus sativus in mice. Iranian J Basic Med Sci. 2001;4:11\u201315."}, {"Citation": "Hosseinzadeh H, Younesi H. Petal and stigma extracts of Crocus sativus L. have antinociceptive and anti-inflammatory effects in mice. BMC Pharmacol. 2002;2:7. doi: 10.1186/1471-2210-2-7.", "ArticleIdList": ["10.1186/1471-2210-2-7", "PMC101384", "11914135"]}, {"Citation": "Addullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.) Exp Biol Med. 2002;227:20\u201325.", "ArticleIdList": ["11788779"]}, {"Citation": "Abe K, Saito H. Effects of saffron and its constituent crocin on learning behavior and long-term potentiation. Phytother Res. 2000;14:149\u201352. doi: 10.1002/(SICI)1099-1573(200005)14:3<149::AID-PTR665>3.3.CO;2-X.", "ArticleIdList": ["10.1002/(SICI)1099-1573(200005)14:3<149::AID-PTR665>3.3.CO;2-X", "10815004"]}, {"Citation": "American Psychiatric Association . American Psychiatric Association, Washington, DC. 4 1994. Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV)"}, {"Citation": "Hamilton M. A rating scale for depression. J Neurol Neurosurg. 1960;3:62\u201366.", "ArticleIdList": ["PMC495331", "14399272"]}]}], "History": [{"Year": "2004", "Month": "4", "Day": "23"}, {"Year": "2004", "Month": "9", "Day": "2"}, {"Year": "2004", "Month": "9", "Day": "3", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "10", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "9", "Day": "3", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "9", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["15341662", "PMC517724", "10.1186/1472-6882-4-12", "1472-6882-4-12"]}}], "PubmedBookArticle": []}